Article Information
History
- August 1, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Kamyar Yazdani1,
- Deondre Jordan1,
- Mo Yang1,
- Christopher R. Fullenkamp1,
- Timothy E. H. Allen2,
- Rabia T. Khan2 and
- John S. Schneekloth Jr.1,*
- 1Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA
- 2Ladder Therapeutics, USA
- ↵*E-mail: schneeklothjs{at}mail.nih.gov
Posted August 01, 2022.
